SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001753926-24-000532
Filing Date
2024-03-15
Accepted
2024-03-15 06:04:26
Documents
6
Effectiveness Date
2024-03-15

Document Format Files

Seq Description Document Type Size
1 S-8 g084121_s8.htm S-8 83047
2 EXHIBIT 4.4 g084121_ex4-4.htm EX-4.4 109114
3 EXHIBIT 5.1 g084121_ex5-1.htm EX-5.1 13747
4 EXHIBIT 23.1 g084121_ex23-1.htm EX-23.1 4588
5 EXHIBIT 107 g084121_ex107.htm EX-FILING FEES 12057
6 GRAPHIC image_ex51v1.jpg GRAPHIC 7460
  Complete submission text file 0001753926-24-000532.txt   234138
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277961 | Film No.: 24752367
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)